Skip to content

Biomarin Pharmaceutical Inc.

American company

BMRN Nasdaq SEC CIK 1048477

Follow Biomarin Pharmaceutical Weekly email: filings, results, news

News

6 stories filed under Biomarin Pharmaceutical, grouped into ongoing threads

Transcript

Thread · 2 stories

BioMarin Pharmaceutical Inc. (BMRN) Presents at Canaccord Genuity's 46th Annual Growth Conference Transcript

Markets 43 d ago

BioMarin Pharmaceutical Inc. (BMRN) Q2 2026 Earnings Call Transcript

Earnings 49 d ago

More coverage

BioMarin (BMRN) Secured 20% U.S. Royalties on Yuviwel. Is Monetizing a Rival Better than Blocking It?

Markets 20 d ago

BioMarin Pharmaceutical (BMRN)’s Alesta Deal Adds New Growth Potential in Rare Diseases

Markets 36 d ago

Why is BioMarin Pharmaceutical stock surging today?

Markets 37 d ago

BioMarin Pharmaceutical Inc. 2026 Q2 - Results - Earnings Call Presentation

Earnings 48 d ago

Next results

NOV6

FY 2026 results

Friday · estimated from the filing cadence

Profile

Headquarters: NOVATO, CA, United States
Founded: 1997
CEO: Jean Jacques Bienaime
Sector: Healthcare
Industry: Pharmaceutical Preparations
Website: biomarin.com

Peers

Where this page comes from

Profile · SEC EDGAR, Wikidata

Next results · estimated from the filing cadence (SEC EDGAR)

News · 6 stories clustered from the RSS aggregator